PetIQ Inc (PETQ)
17.62
+0.58
(+3.40%)
USD |
NASDAQ |
May 06, 16:00
17.62
0.00 (0.00%)
After-Hours: 20:00
PetIQ Accounts Receivable (Quarterly): 126.84M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 126.84M |
September 30, 2023 | 151.68M |
June 30, 2023 | 193.57M |
March 31, 2023 | 203.32M |
December 31, 2022 | 104.61M |
September 30, 2022 | 125.02M |
June 30, 2022 | 168.83M |
March 31, 2022 | 179.06M |
December 31, 2021 | 108.05M |
September 30, 2021 | 116.19M |
June 30, 2021 | 148.91M |
March 31, 2021 | 162.15M |
December 31, 2020 | 96.38M |
September 30, 2020 | 95.32M |
June 30, 2020 | 140.00M |
Date | Value |
---|---|
March 31, 2020 | 124.84M |
December 31, 2019 | 67.55M |
September 30, 2019 | 95.44M |
June 30, 2019 | 85.13M |
March 31, 2019 | 65.47M |
December 31, 2018 | 45.01M |
September 30, 2018 | 53.59M |
June 30, 2018 | 50.91M |
March 31, 2018 | 58.96M |
December 31, 2017 | 21.76M |
September 30, 2017 | 24.84M |
June 30, 2017 | 31.74M |
March 31, 2017 | 27.33M |
December 31, 2016 | 17.20M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
67.55M
Minimum
Dec 2019
203.32M
Maximum
Mar 2023
131.21M
Average
125.02M
Median
Sep 2022
Accounts Receivable (Quarterly) Benchmarks
Dynavax Technologies Corp | 40.61M |
Pacira BioSciences Inc | 105.56M |
Supernus Pharmaceuticals Inc | 144.16M |
Esperion Therapeutics Inc | 48.49M |
Deciphera Pharmaceuticals Inc | 31.95M |